Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-08-26
1997-07-01
Weimar, Elizabeth C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 12, 514 13, 514 14, 514 15, 514 18, 530307, 530328, 530330, A61K 3800, C07K 706, C07K 512, C07K 510
Patent
active
056438729
ABSTRACT:
This invention relates to compounds of the formula: ##STR1## wherein: A' is absent, Asn, Gln, Ala or Abu;
REFERENCES:
patent: 4578079 (1986-03-01), Ruoslahti et al.
patent: 4683291 (1987-07-01), Zimmermann et al.
patent: 4857508 (1989-08-01), Adams et al.
Pierschbacher et al., J. Biol. Chem., 262, 17294(1987).
Plow et al., Proc. Natl. Acad. Sci., 82, 8057 (1985).
Haverstick et al., Blood, 66, 946 (1985).
Pierschbacher et al., Proc. Natl. Acad. Sci., 81, 5985 (1984).
Yasuda et al., Clin. Res., 94, 2, 634A (1986).
Coller et al., Blood, 66, 1456 (1985).
Nievelstein et al., Thromb. and Hemostasis, 58, 2133 (1987).
Ali Fadia El-Fehail
Samanen James Martin
Kinzig Charles M.
Lentz Edward T.
Marshall S. G.
SmithKline Beecham Corporation
Weimar Elizabeth C.
LandOfFree
Cyclic anti-aggregatory peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclic anti-aggregatory peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic anti-aggregatory peptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-597032